logo
Sign in

NUVA Stock Price, Chart, Stats & News

NuVasive, Inc.
Save
2.08B
Market cap
75.00x
Current P/E
Forward P/E

NUVA chart

1M
3M
1Y
5Y
Loading chart...

Fundamentals

Gross margin
72.00%
Operating margin
5.39%
Pretax margin
4.35%
Net margin
3.36%
Effective tax rate
22.77%
ROA
1.82%
ROE
4.86%
D/E
1.16x
Interest coverage ratio
3.72x

NUVA valuation

P/E
75.00x
P/S
1.73x
P/B
2.62x
P/CF
13.48x
P/FCF
70.22x
P/OCF
13.48x
PEG
0.56x
EV multiple
8.93x

About

NuVasive, Inc. is a medical technology firm focused on creating, producing, and distributing comprehensive procedural solutions for spinal operations. The company offers a range of surgical access instruments, such as the Maxcess integrated split-blade retractor system, which facilitates less-invasive surgical approaches by significantly reducing soft tissue disruption during spinal procedures. Additionally, NuVasive manufactures specialized spinal implants designed to improve spinal fusion by optimizing the osseointegration and biomechanical characteristics of materials like porous titanium and porous polyetheretherketone.

Similar securities

Based on sector and market capitalization

Report issue